A study comparing P2Y12 Inhibitors in Australian patients undergoing PCI has found that prasugrel in combination with aspirin was associated with better two-year outcomes compared to ticagrelor and clopidogrel. Prasugrel had significantly lower rates of the composite outcome of death, myocardial infarction and stroke at one and two years after PCI compared to other P2Y12 ...
Antiplatelets compared: one stands out from others in Australian PCI study
By Michael Woodhead
31 Aug 2020